Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
08/04/2011 | WO2011091562A1 Method for breeding transgenic animals with enhanced expression of porcine growth hormone |
08/04/2011 | WO2011091475A1 Method for stem cell differentiation |
08/04/2011 | WO2011070214A3 Conjugates and compositions for immunotherapy and anti-tumor treatment |
08/04/2011 | WO2011069124A3 Method, system and composition for optically inducing cardiomyocyte contraction |
08/04/2011 | WO2011063039A9 Methods of inducing tissue regeneration |
08/04/2011 | WO2011037835A3 Medium for handling and storing biological tissues of the musculoskeletal system outside an organism |
08/04/2011 | WO2011035030A3 Induction of neuronal differentiation in non-neuronal cells using a nucleic acid molecule |
08/04/2011 | WO2011034605A3 Coiled coil and/or tether containing protein complexes and uses thereof |
08/04/2011 | WO2011022725A3 Mimotopes of hiv and uses thereof |
08/04/2011 | WO2010115052A3 Induced pluripotent stem cells |
08/04/2011 | US20110191915 Influenza virus immunizing epitope |
08/04/2011 | US20110191914 Targeted Integration and Stacking of DNA Through Homologous Recombination |
08/04/2011 | US20110191913 Cells producing glycoproteins having altered glycosylation patterns and method and use thereof |
08/04/2011 | US20110191912 Promoter, promoter control elements, and combinations, and uses thereof |
08/04/2011 | US20110191911 Method for the alteration of plants using cle polypeptides/peptides |
08/04/2011 | US20110191909 Materials and methods for modulating seed size, seed number, and seed sugar content in plants |
08/04/2011 | US20110191906 Marchantiales-derived unsaturated fatty acid synthetase genes and use of the same |
08/04/2011 | US20110191905 Modification of Fatty Acid Biosynthesis using Recombinant Diacylglycerol Acyltransferase Sequences from Rygrass (lolium) and Fescue (festuca) |
08/04/2011 | US20110191903 Engineering plant resistance to diseases caused by pathogens |
08/04/2011 | US20110191902 Methods and Compositions for Increasing Storage-Life of Fruit |
08/04/2011 | US20110191898 Compositions and Methods for Enhanced Amino Acid Levels in Plants |
08/04/2011 | US20110191897 Plants Tolerant to HPPD Inhibitor Herbicides |
08/04/2011 | US20110191896 Methods and compositions for increasing plant disease resistance and yield |
08/04/2011 | US20110191895 Plant farnesyltransferases |
08/04/2011 | US20110191894 Methods and compositions relating to conrolled induction of plant senescence |
08/04/2011 | US20110191892 Genetic markers associated with drought tolerance in maize |
08/04/2011 | US20110191878 Msca1 nucleotide sequences impacting plant male fertility and method of using same |
08/04/2011 | US20110191877 Excision of transgenes in genetically modified organisms |
08/04/2011 | US20110191875 Compositions and methods for making androstenediones |
08/04/2011 | US20110191874 Compositions and methods for detecting and modulating cell death by a translation regulated gene expression system |
08/04/2011 | US20110191873 Methods of Protein Destabilization and Uses Thereof |
08/04/2011 | US20110191872 Method for the humanization of antibodies and humanized antibodies thereby obtained |
08/04/2011 | US20110191871 Methods to identify factors associated with muscle growth and uses thereof |
08/04/2011 | US20110191870 I-crei homing endonuclease variants having novel cleavage specificity and use therof |
08/04/2011 | US20110191868 Methods for identification and use of agents targeting cancer stem cells |
08/04/2011 | US20110191866 Methods of making monoclonal antibodies using fusion-peptide epitope adoptive transfer (f-peat) technology |
08/04/2011 | US20110191865 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
08/04/2011 | US20110190886 Braided tertiary nanofibrous structure for ligament, tendon, and muscle tissue implant |
08/04/2011 | US20110190730 Methods of inducing pluripotency involving oct4 protein |
08/04/2011 | US20110190729 Methods of inducing pluripotency involving sox2 protein |
08/04/2011 | US20110190679 Extracorporeal cell-based therapeutic device and delivery system |
08/04/2011 | US20110190623 Thermally-activatable liposome compositions and methods for imaging, diagnosis and therapy |
08/04/2011 | US20110190388 Ursolic acid derivative and pharmaceutical composition thereof |
08/04/2011 | US20110190386 Aptamer Inhibitors of Osteopontin and Methods of Use Thereof |
08/04/2011 | US20110190385 Methods and Products for Reawakening Retrocyclins |
08/04/2011 | US20110190375 Compositions comprising cmyc sirna and methods of use thereof |
08/04/2011 | US20110190374 Methods of treating a meiotic kinesin associated disease |
08/04/2011 | US20110190371 Genetic suppression and replacement |
08/04/2011 | US20110190370 Modulation of hif1(alpha) and hif2(alpha) expression |
08/04/2011 | US20110190343 Hiv-1 fusion inhibitors and methods |
08/04/2011 | US20110190325 Compounds, their syntheses, and thier uses |
08/04/2011 | US20110190316 Substituted pyridines, and use thereof as Gsk3 inhibitors |
08/04/2011 | US20110190315 Indoline scaffold shp-2 inhibitors and cancer treatment method |
08/04/2011 | US20110190298 4-phenoxymethylpiperidines as modulators of gpr119 activity |
08/04/2011 | US20110190287 Thrombocyte Inhibition Via Vivo-Morpholino Knockdown of Alpha IIB |
08/04/2011 | US20110190263 Compounds and compositions as modulators of gpr119 activity |
08/04/2011 | US20110190237 Macrocyclic Prodrug Compounds Useful as Therapeutics |
08/04/2011 | US20110190223 Hemcm42 nucleic acids |
08/04/2011 | US20110190216 Materials and methods for treatment of spinal muscular atrophy and taxane-induced peripheral neuropathy (tipn) |
08/04/2011 | US20110190212 Cyclic tetrapeptides |
08/04/2011 | US20110190166 Erythroid progenitor cells and methods for producing parvovirus b19 therein |
08/04/2011 | US20110190164 Chimeric fusion proteins and virus like particles from birnavirus vp2 |
08/04/2011 | US20110190159 Multi-chain eukaryotic display vectors and uses thereof |
08/04/2011 | US20110190154 Methods and compositions for determining the purity of chemically synthesized nucleic acids |
08/04/2011 | US20110190152 Pluripotency associated epigenetic factor |
08/04/2011 | US20110189775 Targeted genomic alteration |
08/04/2011 | US20110189774 Plant centromere compositions |
08/04/2011 | US20110189773 Silk fibroin fiber bundles for matrices in tissue engineering |
08/04/2011 | US20110189772 Bioreactor with dual compartment |
08/04/2011 | US20110189771 Novel Imino Sugar Derivatives Demonstrate Potent Antiviral Activity and Reducted Toxicity |
08/04/2011 | US20110189770 Endosome-Disrupting Compositions and Conjugates |
08/04/2011 | US20110189769 Methods and compositions for manipulating the guided navigation of endothelial tubes during angiogenesis |
08/04/2011 | US20110189768 Mesenchymal Stem Cells Expressing TNF-alpha Receptors |
08/04/2011 | US20110189767 Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same |
08/04/2011 | US20110189751 Methods and compositions comprising heat shock proteins |
08/04/2011 | US20110189737 Methods for producing hyaluronan in a recombinant host cell |
08/04/2011 | US20110189734 Novel methods and cell lines |
08/04/2011 | US20110189731 Polynucleotides encoding recombinant lubricin molecules and uses thereof |
08/04/2011 | US20110189730 Viral nucleocapsid protein as a multifunctional translation initiation factor and increased protein and polypeptide production using same |
08/04/2011 | US20110189729 Novel recombination sequences |
08/04/2011 | US20110189711 Paad domain-containing polypeptides, encoding nucleic acids, and methods of use |
08/04/2011 | US20110189706 Process for the measurement of the potency of glatiramer acetate |
08/04/2011 | US20110189696 Monoclonal antibody stro-4 |
08/04/2011 | US20110189689 Riboswitches |
08/04/2011 | US20110189658 Cell, method and kit for conducting an assay for neutralizing antibodies |
08/04/2011 | US20110189648 Post-thaw survival of cryopreserved biological material by hydrostatic pressure challenge |
08/04/2011 | US20110189339 Genes for plant fatty acid modifying enzymes associated with conjugated double bond formation |
08/04/2011 | US20110189318 Methods for enhancing the expression of intracellular redox-associated factors |
08/04/2011 | US20110189287 Methods and compositions for wound healing |
08/04/2011 | US20110189285 Hydrogel capable of containing and conveying cells |
08/04/2011 | US20110189284 Peptide Fibres |
08/04/2011 | US20110189233 Recombinant Varicella-Zoster Virus |
08/04/2011 | US20110189232 RECOMBINANT HUMAN PARAINFLUENZA TYPE 1 VIRUSES (HPIV1s) CONTAINING MUTATIONS IN OR DELETION OF THE C PROTEIN ARE ATTENUATED IN AFRICAN GREEN MONKEYS AND IN CILIATED HUMAN AIRWAY EPITHELIAL CELLS AND ARE POTENTIAL VACCINE CANDIDATES FOR HPIV1 |
08/04/2011 | US20110189218 Plasmodium vivax hybrid circumsporozoite protein and vaccine |
08/04/2011 | US20110189214 Cdca1 epitope peptides and vaccines containing the same |
08/04/2011 | US20110189213 Mybl2 epitope peptides and vaccines containing the same |
08/04/2011 | US20110189211 Stem cell populations and methods of use |
08/04/2011 | US20110189207 Methods for soluble zalpha11 cytokine receptors |
08/04/2011 | US20110189206 Antibody Targeting Through a Modular Recognition Domain |
08/04/2011 | US20110189205 Methods of treating cancer using an agent that modulates activity of the calcitonin-gene related peptide ("cgrp") receptor |